VIBRIO GENE EXPRESSION DURING INFECTION
感染期间的弧菌基因表达
基本信息
- 批准号:6373551
- 负责人:
- 金额:$ 11.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from the applicant's abstract): The pathogenicity of
Vibrio cholerae, which infects mucosal surfaces in the small intestine, is
believed to be a coordinated and multifactorial process. Unfortunately,
knowledge of which genes are expressed during infection, as well as the
regulatory proteins and host signals that govern their regulation, is
rudimentary. A novel gene reporter system has been constructed for
identifying in vivo induced genes of V. cholerae, and has been used to
identify the vie (V. cholerae in vivo expressed) operon. vie is predicted
to encode three two-component signal transduction proteins, including a
sensor and two response regulators, the first such system described in V.
cholerae. vie is unique among such systems both in its operon structure and
its exclusive expression during infection. Based on analogy to other
systems, it is hypothesized that the Vie proteins function by sensing
environmental conditions in the host intestine and responding by regulating
other genes. Characterization of vie thus provides a unique opportunity
both to probe the host signals and bacterial regulatory proteins that
control V. cholerae growth and pathogenicity as well as to allow
investigation of vie-regulated genes. The goals of this research proposal
are to characterize the vie operon and to identify and characterize
vie-regulated genes. Mutations will be constructed in both vie and
vie-regulated genes, and the effects of each on pathogenicity will be
measured. The subcellular locations of the Vie proteins will be determined
using immunochemical methods. The spatial and temporal expression patterns
of the vie operon and vie-regulated genes will be determined during
infection. This work may contribute to development of mucosal vaccines and
to identification of new targets for therapies against mucosal pathogens.
描述(改编自申请人的摘要):致病性
霍乱弧菌感染小肠粘膜表面,
被认为是一个协调的、多因素的过程。 很遗憾,
了解哪些基因在感染过程中表达,以及
调节蛋白和控制其调节的宿主信号是
简陋的。 构建了一种新型基因报告系统
鉴定霍乱弧菌体内诱导基因,并已用于
识别 vie(霍乱弧菌体内表达)操纵子。 vie被预测
编码三个双组分信号转导蛋白,包括
传感器和两个响应调节器,V 中描述的第一个此类系统。
霍乱。 vie 在此类系统中的独特之处在于其操纵子结构和
其在感染期间的独特表达。 基于与其他的类比
系统中,假设 Vie 蛋白通过感知来发挥作用
宿主肠道的环境条件并通过调节做出反应
其他基因。 因此,vie 的表征提供了一个独特的机会
两者都可以探测宿主信号和细菌调节蛋白
控制霍乱弧菌的生长和致病性,并允许
vi调控基因的研究。 本研究计划的目标
是表征 vie 操纵子并识别和表征
vie调控的基因。 突变将在 vie 和
vie 调节的基因,每个基因对致病性的影响将是
测量。 Vie 蛋白的亚细胞位置将被确定
使用免疫化学方法。 空间和时间表达模式
vie操纵子和vie调控基因的确定将在
感染。 这项工作可能有助于粘膜疫苗和疫苗的开发
确定针对粘膜病原体的治疗新靶点。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Novel approaches to monitor bacterial gene expression in infected tissue and host.
监测受感染组织和宿主中细菌基因表达的新方法。
- DOI:10.1016/s1369-5274(99)00058-2
- 发表时间:2000
- 期刊:
- 影响因子:0
- 作者:Lee,SH;Camilli,A
- 通讯作者:Camilli,A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Camilli其他文献
Andrew Camilli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Camilli', 18)}}的其他基金
Targeting antibiotic resistance genes in Vibrio cholerae using a phage-encoded CRISPR-Cas system to improve efficacy of phage prophylaxis
使用噬菌体编码的 CRISPR-Cas 系统靶向霍乱弧菌中的抗生素抗性基因,以提高噬菌体预防的功效
- 批准号:
10320480 - 财政年份:2021
- 资助金额:
$ 11.95万 - 项目类别:
Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings
产品优化,以将可在现实环境中预防霍乱的口服噬菌体混合物商业化
- 批准号:
10555220 - 财政年份:2018
- 资助金额:
$ 11.95万 - 项目类别:
Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings
产品优化,以将可在现实环境中预防霍乱的口服噬菌体混合物商业化
- 批准号:
10349544 - 财政年份:2018
- 资助金额:
$ 11.95万 - 项目类别:
Developing a Scalable Manufacturing Process for an Oral Bacteriophage Product that Prevents Cholera
开发预防霍乱的口服噬菌体产品的可扩展制造工艺
- 批准号:
10086723 - 财政年份:2018
- 资助金额:
$ 11.95万 - 项目类别:
Developing a Scalable Manufacturing Process for an Oral Bacteriophage Product that Prevents Cholera
开发预防霍乱的口服噬菌体产品的可扩展制造工艺
- 批准号:
10097213 - 财政年份:2018
- 资助金额:
$ 11.95万 - 项目类别:
Developing a novel strategy to uncover vaccine targets in bacterial pathogens
开发一种新策略来发现细菌病原体中的疫苗靶点
- 批准号:
8990816 - 财政年份:2015
- 资助金额:
$ 11.95万 - 项目类别:
Developing a novel strategy to uncover vaccine targets in bacterial pathogens
开发一种新策略来发现细菌病原体中的疫苗靶点
- 批准号:
8891081 - 财政年份:2015
- 资助金额:
$ 11.95万 - 项目类别:
Impact of Bacteriophages on Virulence and Transmission of Vibrio cholerae
噬菌体对霍乱弧菌毒力和传播的影响
- 批准号:
10548231 - 财政年份:2003
- 资助金额:
$ 11.95万 - 项目类别: